The association between depression and adherence to antiretroviral therapy in HIV-positive patients, KwaZulu-Natal, South Africa

South African Family Practice

Volumn 54, Issue 2, 2012, Pages 145-150

  Kitshoff, Chelline ^a   Campbell, L ^a   Naidoo, S S ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Adherence; Antiretroviral therapy; Depression; HIV AIDS

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ALCOHOL ABUSE; ARTICLE; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; DENIAL; DEPRESSION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; QUESTIONNAIRE; SOCIAL SUPPORT; TRADITIONAL MEDICINE; VIRUS LOAD;

EID: 84904264292     PISSN: 1726426X     EISSN: None     Source Type: Journal    
DOI: 10.1080/20786204.2012.10874194     Document Type: Article

References (38)

1. Lopez A, Mathers C. Measuring the global burden of disease and epidemiological transitions: 2002-2030. Ann Trop Med Parasitol. 2006; 100(5-6): 481-499.
2. Kaplan H, Sadock B, Grebb J. Kaplan and Sadock's synopsis of psychiatry. 7th edition. Baltimore: William & Wilkins; 1994.
3. Ciesla J, Roberts J. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001; 158(5): 725-730.
4. Tomlinson M, Grimsrud A, Stein D, et al. The epidemiology of major depression in South Africa: results from the South African stress and health study. S Afr Med J. 2009; 99: 367-373.
5. Myer L, Smit J, Roux L, et al. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDS. 2008; 22(2): 147-148.
6. Olley B, Seedat S, Stein D. Persistence of psychiatric disorders in a cohort of HIV/AIDS patients in South Africa: a 6-month follow-up study. J Psychosom Res. 2006; 61(4): 479-484.
7. Sherbourne CD, Fleishman JA, Vitiello B, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000; 157: 248-254.
8. Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004; 94(7): 1133-1140.
9. Kacanek D, Jacobson D, Spiegelman D, Wanke C, Isaac R, Wilson I. Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study. J Acquir Immune Defic Syndr. 210; 53(2): 266-272.
10. Meade C, Sikkema K. Psychiatric and psychosocial correlates of sexual risk behavior among adults with severe mental illness. Community Ment Health J. 2007; 43(2): 153-169.
11. Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004 Jun; 291(21): 2581-2590.
12. Olley B, Seedat S, Nei D, Stein D. Predictors of major depression in recently diagnosed patients with HIV/AIDS in South Africa. AIDS Patient Care STDS. 2004; 18(8): 481-487.
13. Journot V, Chene G, Castro ND, et al. Use of efavirenz is not associated with a higher risk of depressive disorders: a substudy of the randomized clinical trial ALIZE-ANRS 099. Clin Infect Dis. 2006 Jun; 42: 1790-1799.
14. Paterson D, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000; 133: 21-30.
15. Horberg M, Silverberg M, Hurley L, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008; 47(3): 384-390.
16. Peltzer K, Friend-du Preez N, Ramlagan S, Anderson J. Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa. BMC Public Health. 2010; 10: 111.
17. Dahab M, Charalambous S, Hamilton R, et al. "That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health. 2008; 8: 63.
18. Joska JA, Stein DJ, Flisher AJ. HIV/AIDS and psychiatry: towards the establishment of a pilot programme for detection and treatment of common mental disorders in people living with HIV/AIDS in Cape Town. South African Journal of Psychiatry 2008; 14(4): 122-124.
19. Naughton M, Wiklund I. A critical review of dimension-specific measures of healthrelated quality of life in cross-cultural research. Qual Life Res. 1993; 2: 397-432.
20. Valenstein M, Vijan S, Zeber JE, et al. The cost-utility of screening for depression in primary care. Ann Intern Med. 2001; 134: 345-360.
21. Pretorius T. Cross-cultural application of the Centre for Epidemiological Studies Depression Scale: a study of black South African students. Psychol Rep. 1991; 69: 1179-1185.
22. Myers K, Winters N. Ten-year review of rating scales I: overview of scale functioning, psychometric properties, and selection. J Am Acad Child Adolesc Psychiatry. 2002; 41(2): 114-122.
23. Kalichman S, Rompa D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nerv Ment Dis. 2000; 188(10): 662-670.
24. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977; 1(3): 385-401.
25. Lio MS, Carbini R, Germano P, et al. Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the Drug Resources Enhancement Against AIDS and Malnutrition Programme in Mozambique. Clin Infect Dis. 2008; 46: 1609-1616.
26. Kaharuza F, Bunnell R, Moss S, et al. Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav. 2006 Jul; 10: S105-111.
27. Kliss K, Velding K, Gidron Y, Peterson K. Posttraumatic stress and depressive symptoms among people living with HIV in the Gambia. AIDS Care. 2011; 24: 1-9.
28. Eller L, Bunch E, Wantland D, et al. Prevalence, correlates, and self-management of HIV-related depressive symptoms. AIDS Care. 2010; 22(9): 1159-1170.
29. Kyser M, Buchacz K, Bush T, et al. Factors associated with non-adherence to antiretroviral therapy in the SUN study. AIDS Care. 2011; 2: 1-11.
30. Patel V. Mental health in low-and middle-income countries. Br Med Bull. 81-82(1): 81-96.
31. Ciesla J, Roberts J. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001; 158: 725-730.
32. Bhat V, Ramburuth M, Singh M, et al. Factors associated with poor adherence to anti-retroviral therapy in patients attending a rural health centre in South Africa. Eur J Clin Microbiol Infect Dis. 2010; 29(8): 947-953.
33. Weiser S, Wolfe W, Bangsberg D, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003 Nov; 1(34): 281-288.
34. Johnson M, Chesney M, Goldstein R, et al. Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIVinfected adults: a mediation model. AIDS Patient Care STDS. 2006; 20(4): 258-268.
35. Willard S. Relationship of emotional intelligence and adherence to combination antiretroviral medications by individuals living with HIV disease. J Assoc Nurses AIDS Care. 2006; 17(2): 16-26.
36. Perreira K, Deeb-Sossa N, Harris K, Bollen K. What are we measuring? An evaluation of the CES-D across race/ethnicity and immigrant generation. Social Forces 2005; 83(4): 1567-1602.
37. Cheever L, Wu A. Medication adherence among HIV-infected patients: understanding the complex behavior of patients taking this complex therapy. Curr Infect Dis Rep. 1999; 1(4): 401-407.
38. Maqutu D, Zewotir T, North D, et al. Determinants of optimal adherence over time to antiretroviral therapy amongst HIV-positive adults in South Africa: a longitudinal study. AIDS Behav. 2010 Mar [Epub ahead of print].